Can fite Biopharma Ltd (CANF) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CANF Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Can fite Biopharma Ltd's financial stability and long-term positioning.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash & cash equivalent5.53
Short-term Investments, Total0.00
Deposits Assets, Current AS3.01
Cash & Short-term Investments8.00
Prepaid Expense And Other Assets Current0.83
Total Current Assets9.44
Equipment/Property/Plant Net0.01
Tax Assets, Noncurrent34.09
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent0.07
Total Assets9.51
Liabilities
Accounts Payable0.30
Accrued Liabilities, Current1.11
Other Liabilities, Current1.62
Total Current Liabilities2.73
Total Long-term Debt0.00
Total Liabilities3.92
Stockholders' Equity
Additional Paid In Capital Common Stock180.65
Retained Earnings / Accumulated Deficit-176.19
Accumulated Other Comprehensive Income1.13
Other Equity1.13
Common Stockholder's Equity5.59
Total Stockholder's Equity5.59
Liabilities & Stockholder's Equity9.51
4 historic quarters locked

Sign in to unlock the full Can fite Biopharma Ltd balance sheet history.

About Can Fite Biopharma Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-034447

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.